FDA label
What is clopidogrel used for?
The FDA-approved uses of clopidogrel, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label for clopidogrel bisulfate (tablet, film coated) lists 2 uses: Acute Coronary Syndrome (ACS); Recent MI, Recent Stroke, or Established Peripheral Arterial Disease.
Run it in Rivvi
Which 2027 plans near you dropped or restricted clopidogrel?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Clopidogrel Bisulfate, tablet, film coated
Indications and Usage, quoted from the label by Dr.Reddy's Laboratories Limited (ANDA076273). Cross-references to other label sections are left out.
Acute Coronary Syndrome (ACS)
- Clopidogrel tablets are indicated to reduce the rate of myocardial infarction (MI) and stroke in patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI)], including patients who are to be managed medically and those who are to be managed with coronary revascularization. Clopidogrel tablets should be administered in conjunction with aspirin.
- Clopidogrel tablets are indicated to reduce the rate of myocardial infarction and stroke in patients with acute ST-elevation myocardial infarction (STEMI) who are to be managed medically. Clopidogrel tablets should be administered in conjunction with aspirin.
Recent MI, Recent Stroke, or Established Peripheral Arterial Disease
In patients with established peripheral arterial disease or with a history of recent myocardial infarction (MI) or recent stroke clopidogrel tablets are indicated to reduce the rate of MI and stroke.
Source: DailyMed label, set id b5aa951f-72de-bea1-98a2-a4085c64a361, version 24, effective August 28, 2025. NDC 55111-196, one of 48 listings for this product.
Clopidogrel, tablet
Indications and Usage, quoted from the label by Camber Pharmaceuticals, Inc. (ANDA205345). Cross-references to other label sections are left out.
Acute Coronary Syndrome (ACS)
- Clopidogrel tablets are indicated to reduce the rate of myocardial infarction (MI) and stroke in patients with non–ST-segment elevation ACS (unstable angina [UA]/non–ST-elevation myocardial infarction [NSTEMI]), including patients who are to be managed medically and those who are to be managed with coronary revascularization. Clopidogrel tablets should be administered in conjunction with aspirin.
Recent MI, Recent Stroke, or Established Peripheral Arterial Disease
In patients with established peripheral arterial disease or with a history of recent myocardial infarction (MI) or recent stroke clopidogrel tablets are indicated to reduce the rate of MI and stroke.
Source: DailyMed label, set id b573aefa-e337-478f-97e4-eb8472a7e497, version 1, effective September 8, 2023. NDC 31722-758, one of 2 listings for this product.
Questions
What is clopidogrel used for?
The FDA label for clopidogrel bisulfate (tablet, film coated) lists 2 uses: Acute Coronary Syndrome (ACS); Recent MI, Recent Stroke, or Established Peripheral Arterial Disease.
What drug class is clopidogrel?
FDA lists clopidogrel in the P2Y12 Platelet Inhibitor established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Clopidogrel
- Is Clopidogrel a controlled substance?Federal schedule
- Generic for PlavixFDA Orange Book
- What is Plavix used for?FDA label uses
- Is Plavix a controlled substance?Federal schedule
- P2Y12 Platelet Inhibitors listFDA drug class
- NDC 0024-1171Clopidogrel NDC record
- NDC 0024-1332Clopidogrel NDC record
- NDC 0093-7314Clopidogrel NDC record